Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Ibio Inc (IBIO) USD0.001

Sell:$0.44 Buy:$0.48 Change: $0.098 (17.03%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
Sell:$0.44
Buy:$0.48
Change: $0.098 (17.03%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
Sell:$0.44
Buy:$0.48
Change: $0.098 (17.03%)
Market closed |  Prices as at close on 23 October 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.

Contact details

Address:
600 Madison Ave Ste 1601
NEW YORK
10022-1737
United States
Telephone:
+1 (302) 3550650
Website:
https://www.ibioinc.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
IBIO
ISIN:
US4510332038
Market cap:
$12.08 million
Shares in issue:
24.15 million
Sector:
Biotechnology
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Robert Kay
    Executive Chairman of the Board, Chief Executive Officer
  • Robert Erwin
    President
  • James Mullaney
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.